Fanzen rises 1.78% amid uptrend in biosimilar (biologic drug copy) theme

On the 28th, the biosimilar (generic biopharmaceutical) theme showed strength by rising 3.03% compared to the previous day, while PanGen, a related stock attracting attention, surged by 1.78% compared to the previous day. PanGen is known as a manufacturer of biological products.

[Graph] Major stock price changes in the biosimilar (generic biopharmaceutical) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, PanGen's quant financial score is 6.54 points, which is lower in stability, profitability, and growth scores compared to the average of other stocks related to biosimilars (generic biopharmaceuticals). This can be interpreted as PanGen having relatively low investment attractiveness compared to other stocks from a financial perspective. On the other hand, Dong-A ST ranked first in quant financial ranking with higher stability and profitability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.